0
Signin
countryflagCA

888-969-2592

RY 141.08 0.0851% TD 77.38 0.8077% SHOP 80.58 -5.633% CNR 174.21 0.0862% ENB 51.67 1.0364% CP 113.34 0.3808% BMO 128.16 0.5729% TRI 229.48 -0.0566% CNQ 104.59 -1.4046% BN 60.46 -0.0496% ATD 75.69 1.244% CSU 3736.3 -2.3672% BNS 65.67 0.1831% CM 67.55 0.5508% SU 54.79 -0.2549% TRP 52.78 1.1111% NGT 58.11 -0.7854% WCN 228.73 0.6778% MFC 35.6 1.1651% BCE 46.39 0.3461%

Sirona Biochem Corp

Healthcare CA SBM

0.07CAD
-(-%)

Last update at 2024-05-10T19:51:00Z

Day Range

0.070.07
LowHigh

52 Week Range

0.070.21
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Income before tax -3.55185M -2.31202M -4.14080M -4.55578M -1.15314M
Minority interest - - - - -
Net income -3.55780M -2.30633M -4.13372M -4.54957M -1.27325M
Selling general administrative 2.67M 1.40M 2.96M 3.34M 1.28M
Selling and marketing expenses - - - - -
Gross profit - - - 0.14M 1.28M
Reconciled depreciation 0.00909M 0.00946M 0.00970M - 0.00000M
Ebit -3.38951M -2.13445M -3.99508M -4.19879M -0.85627M
Ebitda -3.51576M -2.29922M -4.11798M -4.43905M -0.92637M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -3.53740M -2.29681M -4.16994M -4.46923M -0.94451M
Other operating expenses - - - - -
Interest expense 0.03M 0.00333M 0.01M 0.12M 0.23M
Tax provision 0.00595M -0.00568M -0.00708M -0.00621M 0.12M
Interest income - - 0.04M - -
Net interest income -0.02700M -0.00333M 0.03M -0.11674M -0.22677M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00595M -0.00568M -0.00708M -0.00621M 0.12M
Total revenue 0.67M 0.27M 0.11M 0.14M 1.28M
Total operating expenses 4.21M 2.56M 4.28M 4.60M 2.22M
Cost of revenue - - - - 0.06M
Total other income expense net 0.01M -0.01187M 0.00160M 0.03M 0.02M
Discontinued operations - - - - -
Net income from continuing ops -3.55780M -2.30633M -4.13372M -4.54957M -1.27325M
Net income applicable to common shares -3.55780M -2.30633M -4.13372M -4.54957M -1.27325M
Preferred stock and other adjustments - - - - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Total assets 1.29M 1.29M 2.14M 4.26M 0.77M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 1.08M 1.38M 2.09M 2.07M 3.03M
Total stockholder equity 0.21M -0.09702M 0.05M 2.19M -2.26097M
Deferred long term liab - - - - -
Other current liab 0.18M 0.11M 0.11M 0.10M 0.15M
Common stock 34.49M 31.21M 29.08M 28.52M 20.40M
Capital stock 34.49M 31.21M 29.08M 28.52M 20.40M
Retained earnings -41.35757M -37.79976M -35.49343M -31.35971M -26.81013M
Other liab 0.12M 0.13M 0.12M 0.10M 0.08M
Good will - - - - -
Other assets - - - - -
Cash 0.42M 0.78M 1.54M 3.73M 0.34M
Cash and equivalents - - - - -
Total current liabilities 0.86M 0.74M 1.03M 0.92M 1.86M
Current deferred revenue - - - - -
Net debt 0.00729M - - - 1.99M
Short term debt - - - 0.47M 1.38M
Short long term debt 0.34M 0.30M 0.26M 0.47M 1.38M
Short long term debt total - - - - -
Other stockholder equity -0.22413M -0.06131M -0.10154M -0.01136M -0.01207M
Property plant equipment 0.02M 0.03M 0.04M - -
Total current assets 1.27M 1.26M 2.10M 4.26M 0.77M
Long term investments - - - - -
Net tangible assets 0.21M -0.09702M 0.05M 2.19M -2.26097M
Short term investments - - - 0.00073M 0.00074M
Net receivables 0.80M 0.44M 0.50M 0.46M 0.30M
Long term debt 0.09M 0.47M 0.85M 0.94M 0.96M
Inventory - - - - -
Accounts payable 0.32M 0.30M 0.62M 0.31M 0.29M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.00000M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 0.02M 0.03M 0.04M 0.00000M 0.00000M
Capital lease obligations 0.04M 0.08M 0.13M 0.14M 0.18M
Long term debt total - - - - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Investments - - -0.04697M - 0.00000M
Change to liabilities 0.09M -0.29469M 0.41M 0.06M -0.02169M
Total cashflows from investing activities - - -0.04697M -0.04697M -0.04697M
Net borrowings -0.33837M -0.30826M -0.13338M -0.24060M -0.21972M
Total cash from financing activities 2.04M 1.45M -0.04596M 6.96M 0.66M
Change to operating activities -0.02262M 0.05M 0.02M 0.09M -0.02269M
Net income -3.55780M -2.30633M -4.13372M -4.54957M -1.27325M
Change in cash -0.35649M -0.75787M -2.19877M 3.40M 0.07M
Begin period cash flow 0.78M 1.54M 3.73M 0.34M 0.27M
End period cash flow 0.42M 0.78M 1.54M 3.73M 0.34M
Total cash from operating activities -2.17751M -2.15823M -2.11210M -3.55949M -0.59335M
Issuance of capital stock - - 0.00000M 3.14M 0.60M
Depreciation 0.00909M 0.00946M 0.00970M 0.00970M 0.00970M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.36043M 0.05M -0.03450M -0.14538M 0.41M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome 1.67M 0.34M 1.62M 0.99M 0.32M
Capital expenditures 0.00000M 0.00000M 0.05M 0.05M 0.05M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.29548M -0.19844M 0.39M 0.00046M 0.36M
Stock based compensation 1.46M 0.33M 1.62M 1.06M -
Other non cash items 0.20M - 0.00246M 0.03M 0.24M
Free cash flow -2.17751M -2.15823M -2.15907M -3.55949M -0.65380M

Fundamentals

  • Previous Close 0.07
  • Market Cap29.01M
  • Volume1000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.06504M
  • Revenue TTM0.08M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.62M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SBM
Sirona Biochem Corp		 - -% 0.07 - - 343.74 41.64 359.74 -13.882
NGEN
NervGen Pharma Corp		 0.05 2.48% 2.07 - - - 29.48 -6.9477
ARCH
Arch Biopartners Inc		 0.01 0.59% 1.71 - - 37.82 - 53.05 -28.1027
MIR
MedMira Inc		 -0.005 5.56% 0.09 - - 170.46 - 189.94 -48.7372
TTI
Thiogenesis Therapeutics Corp.		 0.03 4.29% 0.73 - - - 11.86 -163.0787

Reports Covered

Stock Research & News

View All

Profile

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Sirona Biochem Corp

595 Burrard Street, Vancouver, BC, Canada, V7X 1L4

Key Executives

Name Title Year Born
Dr. Howard J. Verrico M.D., Ph.D. Founder, Chairman, CEO & Sec. 1961
Mr. Christopher D. Hopton C.G.A., C.P.A. CFO & Director 1966
Dr. Géraldine Deliencourt-Godefroy Ph.D. Chief Scientific Officer & Director NA
Ms. Michelle Seltenrich MBA VP of Operations NA
Dr. Brett A. Premack Ph.D. Scientific Consultant NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).